SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001493152-20-016118
Filing Date
2020-08-17
Accepted
2020-08-17 18:49:50
Documents
1
Period of Report
2020-06-30
Effectiveness Date
2020-08-18

Document Format Files

Seq Description Document Type Size
1 formnt10-q.htm NT 10-Q 39818
  Complete submission text file 0001493152-20-016118.txt   41180
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 201111088
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences